Keywords: proteinase, inhibitor, phase, iii, testing, hoffmann-la, roche

PROTEINASE INHIBITOR IN PHASE III TESTING

Article | 07 February 1994

Print This

Hoffmann-La Roche says that its proteinase inhibitor compound, Ro 31-8959, has begun Phase III clinical testing in the USA as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in